Free Trial Information
BioCentury | Dec 19, 2019

Promoting calcium channel signaling in muscle to treat age-related atrophy

...Falcone, Sorbonne University, Paris, France email: sestinaf@gmail.com CONTACT: France Piétri-Rouxel, same affiliation as above email: france.pietri-rouxel@upmc.fr Claire Quang Sorbonne University Calcium...
Read More
BioCentury | Nov 6, 2019

Peptide inhibitors of a histone chaperone for osteosarcoma and breast cancer

...culture; mice LICENSING STATUS: Patented by the French Alternative Energies and Atomic Energy Commission and Sorbonne University...
Read More
BioCentury | Aug 28, 2019
Distillery Therapeutics

Lipid metabolism regulator ACBP identified as target in obesity

...published online Aug. 15, 2019 doi:10.1016/j.cmet.2019.07.010 CONTACT: Guido Kroemer, Sorbonne University, Paris, France email: kroemer@orange.fr Claire Quang Sorbonne University Obesity...
Read More
BioCentury | May 3, 2019
Company News

Management tracks: Eisai, Nektar, ABPI

...the Institute for Memory and Alzheimer's Disease, European Center of Excellence in Neurodegenerative Disease at Sorbonne University...
Read More
BioCentury | Jan 23, 2019
Distillery Therapeutics

Ophthalmic disease

...published online Jan. 9, 2019 doi:10.1126/sciadv.aau9940 CONTACT: Francine Behar-Cohen, Sorbonne University, Paris, France email: francine.behar@gmail.com Claire Quang Sorbonne University Transferrin Retinal...
Read More
BioCentury | Apr 10, 2018
Distillery Techniques

Drug platforms

...INSERM), Paris, France email: jean-paul.concordet@mnhn.fr Jennie Walters Institut National de la Sante et de la Recherche Medicale (INSERM) Sorbonne University Adeno-associated...
Read More
BioCentury | Apr 25, 2017
Distillery Therapeutics

Musculoskeletal

...Sorbonne University, Paris, France email: capucine.trollet@upmc.fr CONTACT: G. Dickson, University of London, London, U.K. email: g.dickson@rhul.ac.uk Winnie Pong Sorbonne University University...
Read More
BioCentury | Feb 19, 2015
Distillery Therapeutics

Therapeutics: Kallikrein-related peptidase 5 (KLK5); KLK7; KLK14; suppression of tumorigenicity 14 (ST14; matriptase)

Dermatology INDICATION: Dermatology In vitro and mouse studies have identified coumarin-3-carboxylate-based protease inhibitors that could help treat skin diseases such as Netherton syndrome, which is characterized by high levels of Kallikrein-related protease activity in the...
Read More
Items per page:
1 - 8 of 8
BioCentury | Dec 19, 2019

Promoting calcium channel signaling in muscle to treat age-related atrophy

...Falcone, Sorbonne University, Paris, France email: sestinaf@gmail.com CONTACT: France Piétri-Rouxel, same affiliation as above email: france.pietri-rouxel@upmc.fr Claire Quang Sorbonne University Calcium...
Read More
BioCentury | Nov 6, 2019

Peptide inhibitors of a histone chaperone for osteosarcoma and breast cancer

...culture; mice LICENSING STATUS: Patented by the French Alternative Energies and Atomic Energy Commission and Sorbonne University...
Read More
BioCentury | Aug 28, 2019
Distillery Therapeutics

Lipid metabolism regulator ACBP identified as target in obesity

...published online Aug. 15, 2019 doi:10.1016/j.cmet.2019.07.010 CONTACT: Guido Kroemer, Sorbonne University, Paris, France email: kroemer@orange.fr Claire Quang Sorbonne University Obesity...
Read More
BioCentury | May 3, 2019
Company News

Management tracks: Eisai, Nektar, ABPI

...the Institute for Memory and Alzheimer's Disease, European Center of Excellence in Neurodegenerative Disease at Sorbonne University...
Read More
BioCentury | Jan 23, 2019
Distillery Therapeutics

Ophthalmic disease

...published online Jan. 9, 2019 doi:10.1126/sciadv.aau9940 CONTACT: Francine Behar-Cohen, Sorbonne University, Paris, France email: francine.behar@gmail.com Claire Quang Sorbonne University Transferrin Retinal...
Read More
BioCentury | Apr 10, 2018
Distillery Techniques

Drug platforms

...INSERM), Paris, France email: jean-paul.concordet@mnhn.fr Jennie Walters Institut National de la Sante et de la Recherche Medicale (INSERM) Sorbonne University Adeno-associated...
Read More
BioCentury | Apr 25, 2017
Distillery Therapeutics

Musculoskeletal

...Sorbonne University, Paris, France email: capucine.trollet@upmc.fr CONTACT: G. Dickson, University of London, London, U.K. email: g.dickson@rhul.ac.uk Winnie Pong Sorbonne University University...
Read More
BioCentury | Feb 19, 2015
Distillery Therapeutics

Therapeutics: Kallikrein-related peptidase 5 (KLK5); KLK7; KLK14; suppression of tumorigenicity 14 (ST14; matriptase)

Dermatology INDICATION: Dermatology In vitro and mouse studies have identified coumarin-3-carboxylate-based protease inhibitors that could help treat skin diseases such as Netherton syndrome, which is characterized by high levels of Kallikrein-related protease activity in the...
Read More
Items per page:
1 - 8 of 8